The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, R. S.
Right arrow Articles by Harding, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, R. S.
Right arrow Articles by Harding, C. V.
The Journal of Immunology, 1999, 163: 1188-1194.
Copyright © 1999 by The American Association of Immunologists

CpG Oligodeoxynucleotides Down-Regulate Macrophage Class II MHC Antigen Processing1

Rose S. Chu*, David Askew*, Erika H. Noss*,{dagger}, Aaron Tobian*, Arthur M. Krieg{ddagger} and Clifford V. Harding2,*

* Department of Pathology, and {dagger} Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH 44106; and {ddagger} Department of Internal Medicine, University of Iowa, Iowa City, IA 52242

Unmethylated CpG motifs in bacterial DNA or short oligodeoxynucleotides (ODN) stimulate cells of the immune system and provide adjuvant activity. CpG DNA directly activates macrophages to secrete IL-12 and TNF-{alpha} and increases transcription of various genes, but its effects on macrophage Ag processing remain uncertain. The effects of CpG ODN on class II MHC (MHC-II) Ag processing and presentation were examined using peritoneal macrophages that were cultured for 18 h with CpG ODN and then pulsed with protein Ags. T cell hybridomas were used to detect presentation of specific peptide:MHC-II complexes. Both CpG ODN and LPS inhibited processing of bovine RNase and hen egg lysozyme. Presentation of exogenous peptides was inhibited to a lesser degree. Treatment of macrophages for 18 h with CpG ODN decreased surface MHC-II expression, as measured by flow cytometry. Furthermore, Northern blot analysis revealed that treatment with CpG ODN decreased I-Ak mRNA. Endocytosis by macrophages, as measured by uptake of fluorescent dextran, was not altered by treatment with CpG ODN. The inhibitory effect of CpG ODN on Ag processing was seen after prolonged (18 h) treatment of macrophages, but not after short treatment (e.g., 2 h) with CpG ODN and protein Ag. Enhancement of macrophage Ag processing was not seen at any time point of CpG ODN exposure, in contrast to data from other studies with dendritic cells. In summary, exposure of macrophages to CpG ODN results in a decrease in macrophage Ag processing and presentation, which is largely mediated by a decrease in synthesis of MHC-II molecules.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
P. Barrionuevo, J. Cassataro, M. V. Delpino, A. Zwerdling, K. A. Pasquevich, C. G. Samartino, J. C. Wallach, C. A. Fossati, and G. H. Giambartolomei
Brucella abortus Inhibits Major Histocompatibility Complex Class II Expression and Antigen Processing through Interleukin-6 Secretion via Toll-Like Receptor 2
Infect. Immun., January 1, 2008; 76(1): 250 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wang, G. Roderiquez, T. Jones, P. McPhie, and M. A. Norcross
Control of In Vitro Immune Responses by Regulatory Oligodeoxynucleotides through Inhibition of pIII Promoter Directed Expression of MHC Class II Transactivator in Human Primary Monocytes
J. Immunol., July 1, 2007; 179(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Wang, E. R. Rayburn, W. Wang, E. R. Kandimalla, S. Agrawal, and R. Zhang
Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy.
Mol. Cancer Ther., August 1, 2006; 5(8): 2106 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Pennini, R. K. Pai, D. C. Schultz, W. H. Boom, and C. V. Harding
Mycobacterium tuberculosis 19-kDa Lipoprotein Inhibits IFN-{gamma}-Induced Chromatin Remodeling of MHC2TA by TLR2 and MAPK Signaling
J. Immunol., April 1, 2006; 176(7): 4323 - 4330.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. K. Pai, M. E. Pennini, A. A. R. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding
Prolonged Toll-Like Receptor Signaling by Mycobacterium tuberculosis and Its 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Induced Regulation of Selected Genes in Macrophages
Infect. Immun., November 1, 2004; 72(11): 6603 - 6614.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Switaj, A. Jalili, A. B. Jakubowska, N. Drela, M. Stoksik, D. Nowis, G. Basak, J. Golab, P. J. Wysocki, A. Mackiewicz, et al.
CpG Immunostimulatory Oligodeoxynucleotide 1826 Enhances Antitumor Effect of Interleukin 12 Gene-Modified Tumor Vaccine in a Melanoma Model in Mice
Clin. Cancer Res., June 15, 2004; 10(12): 4165 - 4175.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. E. Davis, C. V. Maxwell, G. F. Erf, D. C. Brown, and T. J. Wistuba
Dietary supplementation with phosphorylated mannans improves growth response and modulates immune function of weanling pigs
J Anim Sci, June 1, 2004; 82(6): 1882 - 1891.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. D. Marshall, E. M. Hessel, J. Gregorio, C. Abbate, P. Yee, M. Chu, G. V. Nest, R. L. Coffman, and K. L. Fearon
Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells
Nucleic Acids Res., September 1, 2003; 31(17): 5122 - 5133.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kuchtey, M. Pennini, R. K. Pai, and C. V. Harding
CpG DNA Induces a Class II Transactivator-Independent Increase in Class II MHC by Stabilizing Class II MHC mRNA in B Lymphocytes
J. Immunol., September 1, 2003; 171(5): 2320 - 2325.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. R. Tobian, N. S. Potter, L. Ramachandra, R. K. Pai, M. Convery, W. H. Boom, and C. V. Harding
Alternate Class I MHC Antigen Processing Is Inhibited by Toll-Like Receptor Signaling Pathogen-Associated Molecular Patterns: Mycobacterium tuberculosis 19-kDa Lipoprotein, CpG DNA, and Lipopolysaccharide
J. Immunol., August 1, 2003; 171(3): 1413 - 1422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. K. Pai, M. Convery, T. A. Hamilton, W. H. Boom, and C. V. Harding
Inhibition of IFN-{gamma}-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion
J. Immunol., July 1, 2003; 171(1): 175 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
U. Kumaraguru, C. D. Pack, and B. T. Rouse
Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins
J. Leukoc. Biol., May 1, 2003; 73(5): 574 - 583.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. Jiang, H. J. Baker, and B. F. Smith
Mucosal Immunization with Helicobacter, CpG DNA, and Cholera Toxin Is Protective
Infect. Immun., January 1, 2003; 71(1): 40 - 46.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. He, R. Vemulapalli, and G. G. Schurig
Recombinant Ochrobactrum anthropi Expressing Brucella abortus Cu,Zn Superoxide Dismutase Protects Mice against B. abortus Infection Only after Switching of Immune Responses to Th1 Type
Infect. Immun., May 1, 2002; 70(5): 2535 - 2543.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Boldrick, A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu, C. E. Belcher, D. Botstein, L. M. Staudt, P. O. Brown, and D. A. Relman
Stereotyped and specific gene expression programs in human innate immune responses to bacteria
PNAS, January 22, 2002; 99(2): 972 - 977.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. H. Noss, R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding
Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis
J. Immunol., July 15, 2001; 167(2): 910 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. H. Dalpke, S. Opper, S. Zimmermann, and K. Heeg
Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs
J. Immunol., June 15, 2001; 166(12): 7082 - 7089.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Askew, R. S. Chu, A. M. Krieg, and C. V. Harding
CpG DNA Induces Maturation of Dendritic Cells with Distinct Effects on Nascent and Recycling MHC-II Antigen-Processing Mechanisms
J. Immunol., December 15, 2000; 165(12): 6889 - 6895.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. Olszewska, C. D. Partidos, and M. W. Steward
Antipeptide Antibody Responses following Intranasal Immunization: Effectiveness of Mucosal Adjuvants
Infect. Immun., September 1, 2000; 68(9): 4923 - 4929.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.